# INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease

> **NCT05175846** · — · UNKNOWN · sponsor: **Trinitas Global, LLC** · enrollment: 60 (estimated)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05175846
- **Lead sponsor:** Trinitas Global, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175846, "INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05175846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*